{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:52:12Z","timestamp":1782935532916,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04274-3","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:14:19Z","timestamp":1758878059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human epidermal growth factor receptor 2 expression and socio-demographic, clinical, and histopathological characteristics in gastric carcinoma at St Francis Hospital Nsambya, Uganda"],"prefix":"10.1186","volume":"25","author":[{"given":"Steven","family":"Wanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorretti","family":"Nassali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Basimbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joviah","family":"Akulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Nsamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praise","family":"Nimusiima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Muhumuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Othieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwel Dancan","family":"Okuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"3","key":"4274_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534\u201342.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"4274_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.18621\/eurj.1296567","volume":"9","author":"M Gecer","year":"2023","unstructured":"Gecer M, B\u00fcy\u00fckpinarba\u015fili N, Turna S, Be\u015firo\u011flu M, Gucin Z. Comparison of human epidermal growth factor receptor 2 and cancer stem cell markers like CD44 and CD133 expressions with clinicopathological parameters in gastric cancer. Eur Res J. 2023;9(5):1015\u201326.","journal-title":"Eur Res J"},{"key":"4274_CR3","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","DOI":"10.3322\/caac.21660"},{"issue":"14","key":"4274_CR4","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.3748\/wjg.v20.i14.3875","volume":"20","author":"AW Asombang","year":"2014","unstructured":"Asombang AW, Rahman R, Ibdah JA. Gastric cancer in Africa: current management and outcomes. World J Gastroenterol. 2014;20(14):3875\u20139.","journal-title":"World J Gastroenterol"},{"key":"4274_CR5","first-page":"5065707","volume":"2021","author":"F Shokouhi","year":"2021","unstructured":"Shokouhi F, Amiripour A, Raeisi Shahraki H. The main patterns in the trend change of stomach cancer incidence amongst selected African countries. Glob Health Epidemiol Genom. 2021;2021:5065707.","journal-title":"Glob Health Epidemiol Genom"},{"issue":"4","key":"4274_CR6","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.4314\/ahs.v17i4.13","volume":"17","author":"S Obayo","year":"2017","unstructured":"Obayo S, Lukwago L, Orem J, Faulx AL, Probert CS. Gastrointestinal malignancies at five regional referral hospitals in Uganda. Afr Health Sci. 2017;17(4):1051\u20138.","journal-title":"Afr Health Sci"},{"issue":"2","key":"4274_CR7","first-page":"142","volume":"13","author":"M Galukande","year":"2008","unstructured":"Galukande M, Luwaga A, Jombwe J, Fualal J, Kigula-Mugamba J, Kanyike A, et al. Gastric cancer diagnosis and treatment guidelines 2008: Uganda cancer working group. East Cent Afr J Surg. 2008;13(2):142\u20139.","journal-title":"East Cent Afr J Surg"},{"issue":"42","key":"4274_CR8","doi-asserted-by":"publisher","first-page":"69060","DOI":"10.18632\/oncotarget.11264","volume":"7","author":"V Fanotto","year":"2016","unstructured":"Fanotto V, Ongaro E, Rihawi K, Avallone A, Silvestris N, Fornaro L, et al. HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives. Oncotarget. 2016;7(42):69060.","journal-title":"Oncotarget"},{"key":"4274_CR9","doi-asserted-by":"publisher","first-page":"852748","DOI":"10.1155\/2014\/852748","volume":"2014","author":"N Iqbal","year":"2014","unstructured":"Iqbal N, Iqbal N. Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications. Mol Biology Int. 2014;2014:852748.","journal-title":"Mol Biology Int"},{"issue":"19","key":"4274_CR10","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.3748\/wjg.v22.i19.4619","volume":"22","author":"LF Abrahao-Machado","year":"2016","unstructured":"Abrahao-Machado LF, Scapulatempo-Neto C. HER2 testing in gastric cancer: an update. World J Gastroenterol. 2016;22(19):4619.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"4274_CR11","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.5858\/arpa.2021-0394-OA","volume":"146","author":"A Ngaiza","year":"2022","unstructured":"Ngaiza A, Vuhahula E, Yahaya J, Ndayisaba MC, Kawishe GJ, Grenert JP, et al. Evaluation of human epidermal growth factor receptor 2 expression in gastric and gastroesophageal cancers in Tanzania. Arch Pathol Lab Med. 2022;146(12):1523\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"4274_CR12","doi-asserted-by":"crossref","unstructured":"Omulo TM RE. HER2\/Neu Protein Over-Expression in Patients with Gastric and Gastro- Esophageal Junction Carcinoma Seen at Kenyatta National Hospital, Kenya. J Carcinog Mutagen. 2014;05(05):1\u201310.","DOI":"10.4172\/2157-2518.1000186"},{"issue":"11","key":"4274_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4236\/ojgas.2022.1211035","volume":"12","author":"E Hategekimana","year":"2022","unstructured":"Hategekimana E, Ruhangaza D, Hansen C, Musoni E, Rugwizangoga B, Hammel K, et al. Immunohistochemical profile of human epidermal growth factor receptor 2 in gastric cancer in Rwanda. Open Journal of Gastroenterology. 2022;12(11):336\u201346.","journal-title":"Open Journal of Gastroenterology"},{"issue":"37","key":"4274_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030647","volume":"101","author":"Y Chu","year":"2022","unstructured":"Chu Y, Li H, Wu D, Guo Q. HER2 protein expression correlates with Lauren classification and P53 in gastric cancer patients. Medicine. 2022;101(37):e30647.","journal-title":"Medicine"},{"issue":"1","key":"4274_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12876-022-02309-7","volume":"22","author":"H Li","year":"2022","unstructured":"Li H, Li L, Zhang N, Wang Z, Xu N, Linghu E, Chai N. Relationship between HER2 overexpression and long-term outcomes of early gastric cancer: a prospective observational study with a 6-year follow-up. BMC Gastroenterol. 2022;22(1):238.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"4274_CR16","first-page":"178","volume":"62","author":"B Duduyemi","year":"2021","unstructured":"Duduyemi B, Asante EAE, Afihene M. The analysis of human epidermal growth Receptor-2 (HER-2) in gastric cancer in A tertiary hospital in Sub-Saharan africa.: human epidermal growth receptor-2 (HER-2) in gastric cancer. Nigerian Med J. 2021;62(4):178\u201382.","journal-title":"Nigerian Med J"},{"key":"4274_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12029-017-9921-1","volume":"49","author":"P Rajadurai","year":"2018","unstructured":"Rajadurai P, Fatt HK, Ching FY. Prevalence of HER2 positivity and its clinicopathological correlation in locally advanced\/metastatic gastric cancer patients in Malaysia. J Gastrointest Cancer. 2018;49:150\u20137.","journal-title":"J Gastrointest Cancer"},{"issue":"3","key":"4274_CR18","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264\u201379.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4274_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5858\/2010-0454-RAR.1","volume":"135","author":"C Gutierrez","year":"2011","unstructured":"Gutierrez C, Schiff R. HER2: biology, detection, and clinical implications. Arch Pathol Lab Med. 2011;135(1):55\u201362.","journal-title":"Arch Pathol Lab Med"},{"key":"4274_CR20","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell CDJ, Majeed U, Rutenberg MS, Croome KP, Poruk KE, Toskich B, et al. Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma. Vol. 32, Current Oncology. 2025. p. 1\u201322.","DOI":"10.3390\/curroncol32020082"},{"key":"4274_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104617","volume":"207","author":"J Cai","year":"2025","unstructured":"Cai J, Wang W, Cong D, Bai Y, Zhang W. Development of treatment strategies for advanced HER2-positive gastric cancer: insights from clinical trials. Crit Rev Oncol Hematol. 2025;207:104617.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"4274_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s11864-025-01300-0","volume":"26","author":"L He","year":"2025","unstructured":"He L, Liu B, Wang Z, Han Q, Chen H. Evolving landscape of HER2-targeted therapies for gastric cancer patients. Curr Treat Options Oncol. 2025;26(4):260\u201377.","journal-title":"Curr Treat Options Oncol"},{"key":"4274_CR23","doi-asserted-by":"crossref","unstructured":"Ratti M, Citterio C, Orlandi E, Vecchia S, Anselmi E, Toscani I, et al. Fighting HER2 in Gastric Cancer: Current Approaches and Future Landscapes. Int J Mol Sci. 2025;26(15):7285.","DOI":"10.3390\/ijms26157285"},{"issue":"4","key":"4274_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.47717\/turkjsurg.2024.6501","volume":"40","author":"M Kahiye","year":"2024","unstructured":"Kahiye M, Yahaya J, Kalungi S, Nalwoga H. HER2 immunohistochemical expression and its association with clinicopathological features of gastric adenocarcinoma in Uganda. Turk J Surg. 2024;40(4):328.","journal-title":"Turk J Surg"},{"key":"4274_CR25","doi-asserted-by":"publisher","unstructured":"Fleiss JL, Levin B, Paik, MC. Statistical Methods for Rates and Proportions. 3rd Edition, Wiley, Hoboken. 2003. https:\/\/doi.org\/10.1002\/0471445428.","DOI":"10.1002\/0471445428"},{"issue":"1","key":"4274_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-022-02309-7","volume":"22","author":"H Li","year":"2022","unstructured":"Li H, Li L, Zhang N, Wang Z, Xu N, Linghu E, Chai N. Relationship between HER2 overexpression and long-term outcomes of early gastric cancer: a prospective observational study with a 6-year follow-up. BMC Gastroenterol. 2022;22(1):1\u20137.","journal-title":"BMC Gastroenterol"},{"key":"4274_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1152895","volume":"13","author":"B Xu","year":"2023","unstructured":"Xu B, Chen H, Zhang J, Cong Y, Ning L, Chen L, et al. A comparative study of gastric adenocarcinoma HER2 IHC phenotype and mass spectrometry-based quantification. Front Oncol. 2023;13:1152895.","journal-title":"Front Oncol"},{"issue":"4","key":"4274_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.47717\/turkjsurg.2024.6501","volume":"40","author":"M Kahiye","year":"2024","unstructured":"Kahiye M, Yahaya J, Kalungi S, Nalwoga H. HER2 immunohistochemical expression and its association with clinicopathological features of gastric adenocarcinoma in Uganda. Turk J Surg. 2024;40(4):328\u201335.","journal-title":"Turk J Surg"},{"key":"4274_CR29","doi-asserted-by":"publisher","first-page":"107327482412936","DOI":"10.1177\/10732748241293699","volume":"31","author":"L Shen","year":"2024","unstructured":"Shen L, Li Y, Huang H, Lu Z, Chen B. HER2 in gastric cancer: a comprehensive analysis combining meta-analysis and DCE-MRI radiomics. Cancer Control. 2024;31:10732748241293700.","journal-title":"Cancer Control"},{"key":"4274_CR30","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5624","author":"HH Hu","year":"2024","unstructured":"Hu HH, Wang SQ, Zhao H, Chen ZS, Shi X, Chen XB. HER2(+) advanced gastric cancer: current state and opportunities (review). Int J Oncol. 2024. https:\/\/doi.org\/10.3892\/ijo.2024.5624.","journal-title":"Int J Oncol"},{"issue":"4","key":"4274_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4132\/jptm.2017.04.24","volume":"51","author":"DAT Phan","year":"2017","unstructured":"Phan DAT, Nguyen VT, Hua TNH, Ngo QD, Doan TPT, Nguyen ST, et al. HER2 status and its heterogeneity in gastric carcinoma of Vietnamese patient. J Pathol Transl Med. 2017;51(4):396\u2013402.","journal-title":"J Pathol Transl Med"},{"issue":"1","key":"4274_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-017-1132-5","volume":"15","author":"Y-y Lei","year":"2017","unstructured":"Lei Y-y, Huang J-y, Zhao Q-r, Jiang N, Xu H-m, Wang Z-n, et al. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature. World J Surg Oncol. 2017;15(1):68.","journal-title":"World J Surg Oncol"},{"issue":"19","key":"4274_CR33","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.3748\/wjg.v22.i19.4619","volume":"22","author":"LF Abrahao-Machado","year":"2016","unstructured":"Abrahao-Machado LF, Scapulatempo-Neto C. HER2 testing in gastric cancer: an update. World J Gastroenterol. 2016;22(19):4619\u201325.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"4274_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/PAI.0000000000000219","volume":"24","author":"X Liu","year":"2016","unstructured":"Liu X, Wang X, Wang B, Ren G, Ding W. HER2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in 122 equivocal gastric cancer cases. Appl Immunohistochem Mol Morphol. 2016;24(7):459\u201364.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"4274_CR35","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.15190\/d.2018.6","volume":"6","author":"N Raj","year":"2018","unstructured":"Raj N, Verma D, Kumar A, Rai P, Rao RN. HER2 oncogene amplification and immunohistochemical profiling in gastric adenocarcinoma. Discoveries (Craiova). 2018;6(4):e83.","journal-title":"Discoveries (Craiova)"},{"issue":"null","key":"4274_CR36","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.2147\/OTT.S100643","volume":"9","author":"M Davidson","year":"2016","unstructured":"Davidson M, Starling N. Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives. OncoTargets Therapy. 2016;9(null):7235\u201345.","journal-title":"OncoTargets Therapy"},{"issue":"1","key":"4274_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4155\/cli.10.5","volume":"1","author":"YD Yoon DokHyun","year":"2011","unstructured":"Yoon DokHyun YD, Kang YoonKoo KY. Results and implications of the trastuzumab for gastric cancer (ToGA) trial. Clin Invest. 2011;1(1):87\u201395.","journal-title":"Clin Invest"},{"key":"4274_CR38","doi-asserted-by":"crossref","unstructured":"Wolff AC, Somerfield MR, Dowsett M, Hammond MEH, Hayes DF, Mcshane LM, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update. J Clin Oncol. 2023;41(22):3867\u201372.","DOI":"10.1200\/JCO.22.02864"},{"issue":"3","key":"4274_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00292-010-1278-1","volume":"31","author":"J R\u00fcschoff","year":"2010","unstructured":"R\u00fcschoff J, Nagelmeier I, Baretton G, Dietel M, H\u00f6fler H, Schildhaus HU, et al. [Her2 testing in gastric cancer. What is different in comparison to breast cancer?]. Pathologe. 2010;31(3):208\u201317.","journal-title":"Pathologe"},{"key":"4274_CR40","doi-asserted-by":"crossref","unstructured":".Obayo S, Lukwago L, Orem J, Faulx AL, Probert CS. Gastrointestinal malignancies at five regional referral hospitals in Uganda. Afr Health Sci. 2017;17(4):1051\u20138.","DOI":"10.4314\/ahs.v17i4.13"},{"issue":"8","key":"4274_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082158","volume":"13","author":"WY Kim","year":"2024","unstructured":"Kim WY, Yang EJ, Jang EB, Lee AJ, So KA, Shim S-H, et al. The expression and amplification of HER2 has a significant impact on the prognosis of endometrial carcinoma in Korean patients. J Clin Med. 2024;13(8):2158.","journal-title":"J Clin Med"},{"issue":"6","key":"4274_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/mco.2025.2844","volume":"22","author":"RY Bokhary","year":"2025","unstructured":"Bokhary RY. Prevalence of HER2 expression and its association with clinicopathological parameters in gastric and gastroesophageal junction adenocarcinoma: A 10?year experience of an academic center. Mol Clin Oncol. 2025;22(6):49.","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"4274_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/PAI.0000000000000423","volume":"26","author":"WH Kim","year":"2018","unstructured":"Kim WH, Gomez-Izquierdo L, Vilardell F, Chu KM, Soucy G, Dos Santos LV, et al. HER2 status in gastric and gastroesophageal junction cancer: results of the large, multinational HER-EAGLE study. Appl Immunohistochem Mol Morphol. 2018;26(4):239\u201345.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"4274_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1053\/j.semdp.2021.12.001","volume":"39","author":"H Chen","year":"2022","unstructured":"Chen H, Strickland AL, Castrillon DH. Histopathologic diagnosis of endometrial precancers: updates and future directions. Semin Diagn Pathol. 2022;39(3):137\u201347.","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"4274_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57419-z","volume":"16","author":"L Hohmann","year":"2025","unstructured":"Hohmann L, Sigurjonsdottir K, Campos AB, Nacer DF, Veerla S, Rosengren F, et al. Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer. Nat Commun. 2025;16(1):2208.","journal-title":"Nat Commun"},{"key":"4274_CR46","doi-asserted-by":"publisher","first-page":"S296","DOI":"10.1016\/j.annonc.2022.04.219","volume":"33","author":"X Liu","year":"2022","unstructured":"Liu X, Li H, Zeng L, Lu Z, Chen S, Bibikova M, et al. P-129 evaluation of HER2 status in equivocal gastric cancer tissue samples using surrogate DNA methylation markers. Ann Oncol. 2022;33:S296.","journal-title":"Ann Oncol"},{"key":"4274_CR47","doi-asserted-by":"crossref","unstructured":"Wali RMH, Kama MS. HER2\/neu estimation by ISH (FISH and CISH) technique in equivocal cases (+2) by IHC in breast cancer. Int J Clin Diagnostic Pathol. 2023;6(3):43\u20137.","DOI":"10.33545\/pathol.2023.v6.i3a.535"},{"issue":"7","key":"4274_CR48","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/jclinpath-2017-204928","volume":"71","author":"M Fujimoto","year":"2018","unstructured":"Fujimoto M, Matsuzaki I, Nishino M, Iwahashi Y, Warigaya K, Kojima F, et al. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types. J Clin Pathol. 2018;71(7):600\u20137.","journal-title":"J Clin Pathol"},{"issue":"7","key":"4274_CR49","doi-asserted-by":"publisher","first-page":"e2114180","DOI":"10.1001\/jamanetworkopen.2021.14180","volume":"4","author":"J Lin","year":"2021","unstructured":"Lin J, Zhao Y, Zhou Y, Tian Y, He Q, Lin J, et al. Comparison of survival and patterns of recurrence in gastric neuroendocrine carcinoma, mixed adenoneuroendocrine carcinoma, and adenocarcinoma. JAMA Netw Open. 2021;4(7):e2114180\u2013e.","journal-title":"JAMA Netw Open"},{"key":"4274_CR50","doi-asserted-by":"crossref","unstructured":"Campos SAM, Vilhena Pereira B, Carroll CB, Gon\u00e7alves R, Rondinelli R, Bulzico D. Gastric neuroendocrine neoplasms: analysis of a cohort of patients followed at the Brazilian National Cancer Institute. Endocr Oncol. 2025;5(1).","DOI":"10.1530\/EO-24-0063"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04274-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04274-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04274-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:14:23Z","timestamp":1758878063000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04274-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4274"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04274-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. The study adhered to the Declaration of Helsinki. Ethical approval was granted by St Francis Hospital Nsambya REC Research Ethics Committee (Ref no: SFHN-2023-111). Existing gastric carcinoma tissue blocks at the Pathology laboratory were collected from gastric carcinoma patients who had previously provided written informed consent for using of their tissue blocks for research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"655"}}